Dekker Deacon, MD, PhD

Languages spoken: English

Academic Information

Departments: Dermatology - Visiting Instructor

Academic Office Information

Dekker.Deacon@hsc.utah.edu

(801) 581-2955

School of Medicine
Dept of Dermatology
30 N 1900 E, Room: Rm 4A330
Salt Lake City, UT 84132

Dekker C. Deacon, MD, PhD completed his residency in dermatology at the University of Utah and has a special interest in the genetics of skin cancer and skin cancer treatment, including Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma and others. He is a member of the Melanoma Disease Center, and regularly participates in a weekly melanoma multidisciplinary treatment planning conference. In addition to skin cancer, which he treats at both The Huntsman Cancer Institute and the University of Utah Hospital clinics, Dr. Deacon sees general dermatology patients for a wide range of conditions including Actinic Keratoses, Acne, Warts, Psoriasis, Dermatitis, Rosacea, Hives, Rashes, Skin Lesions, Cysts, Skin Infections, Excessive Sweating, Hair and Nail Disease, and Drug Reactions. In his free time, he enjoys spending time hiking, biking, and skiing with his wife.

Education History

Chief Resident University of Utah School of Medicine
Dermatology 		Chief Resident
Residency University of Utah School of Medicine
Dermatology 		Resident
Internship University of Utah School of Medicine
Internal Medicine Preliminary Year 		Intern
Post Graduate Training University of California, San Diego
Biomedical Sciences 		Ph.D.
Professional Medical University of California, San Diego School of Medicine
Medical Scientist Training Program 		M.D.
Undergraduate Middlebury College
Molecular Biology and Biochemistry 		B.A.

Selected Publications

  1. Kelly BG, Liu T, Deacon DC (2023). Persistent Green-Blue Plaque in a Healthy Woman. JAMA Dermatol, 159(3), 335-336.
  2. Kuceki G, Deacon DC, Secrest AM (2022). Amelanotic Melanoma Treated as Fungal Infection for Years. Case Reports in Dermatological Medicine, 2022(Article ID 2598965), 1-3.
  3. Sahni DR, Deacon DC, Madigan LM (2022). The impact of seasonal temperature variation on the incidence of pernio during the COVID19 pandemic. JAAD Int, 10, 3-5.
  4. Deacon DC, Smith EA, Judson-Torres RL (2021). Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects. Front Med (Lausanne), 8, 642380.
  5. Deacon DC, Madigan LM (2020). Inpatient teledermatology in the era of COVID-19 and the importance of the complete skin examination. JAAD Case Rep, 6(10), 977-978.
  6. Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM (2021). Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol, 156(9), 1004-1011.
  7. Topham C, Deacon DC, Bowen A, Cipriano SD (2019). More than goosebumps: A case of marked skin dimpling in an infant. Pediatr Dermatol, 36(3), e71-e72.
  8. Deacon DC, Happe CL, Chen C, Tedeschi N, Manso AM, Li T, Dalton ND, Peng Q, Farah EN, Gu Y, Tenerelli KP, Tran VD, Chen J, Peterson KL, Schork NJ, Adler ED, Engler AJ, Ross RS, Chi NC (2019). Combinatorial interactions of genetic variants in human cardiomyopathy. Nat Biomed Eng, 3(2), 147-157.
  9. Veevers J, Farah EN, Corselli M, Witty AD, Palomares K, Vidal JG, Emre N, Carson CT, Ouyang K, Liu C, van Vliet P, Zhu M, Hegarty JM, Deacon DC, Grinstein JD, Dirschinger RJ, Frazer KA, Adler ED, Knowlton KU, Chi NC, Martin JC, Chen J, Evans SM (2018). Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem Cells. Stem Cell Reports, 11(3), 828-841.
  10. Hashem SI, Perry CN, Bauer M, Han S, Clegg SD, Ouyang K, Deacon DC, Spinharney M, Panopoulos AD, Izpisua Belmonte JC, Frazer KA, Chen J, Gong Q, Zhou Z, Chi NC, Adler ED (2015). Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure. Stem Cells, 33(7), 2343-50.
  11. Zhang K, Deacon DC, Rao F, Schork AJ, Fung MM, Waalen J, Schork NJ, Nievergelt CM, Chi NC, OConnor DT (2013). Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected]. J Am Coll Cardiol, 63(4), 358-68.
  12. Qiao H, Prasada Rao HB, Yang Y, Fong JH, Cloutier JM, Deacon DC, Nagel KE, Swartz RK, Strong E, Holloway JK, Cohen PE, Schimenti J, Ward J, Hunter N (2014). Antagonistic roles of ubiquitin ligase HEI10 and SUMO ligase RNF212 regulate meiotic recombination. Nat Genet, 46(2), 194-9.
  13. Yoshioka N, Gros E, Li HR, Kumar S, Deacon DC, Maron C, Muotri AR, Chi NC, Fu XD, Yu BD, Dowdy SF (2012). Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell, 13(2), 246-54.
  14. Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE (2010). The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development, 137(11), 1887-96.
  15. Ward JO, Reinholdt LG, Motley WW, Niswander LM, Deacon DC, Griffin LB, Langlais KK, Backus VL, Schimenti KJ, OBrien MJ, Eppig JJ, Schimenti JC (2007). Mutation in mouse hei10, an e3 ubiquitin ligase, disrupts meiotic crossing over. PLoS Genet, 3(8), e139.